Signature substrate mutations associated with HIV-1 protease inhibitor resistance

被引：0
|
作者：
Kolli, M. [1 ]
Stawiski, E. [2 ]
Chappey, C. [2 ]
Parkin, N. [2 ]
Schiffer, C. A. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
[2] Monogram Biosci Inc, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [41] Resistance to HIV-1 protease inhibitors
    Swanstrom, R
    Smith, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 58 - BIOT
  • [42] Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment
    Kagan, R. M.
    Cheung, P. K.
    Huard, T. K.
    Lewinski, M. A.
    ANTIVIRAL RESEARCH, 2006, 71 (01) : 42 - 52
  • [43] Mechanism of substrate binding to HIV-1 protease
    Toth, G
    Borics, A
    Meshkat, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U799 - U799
  • [44] Predicting substrate specificity in HIV-1 protease
    Ozer, N
    Schiffer, CA
    Haliloglu, T
    PROTEIN SCIENCE, 2004, 13 : 193 - 194
  • [45] Analyses of accessory mutations in HIV-1 protease reveal interdependent mechanisms of resistance
    Ragland, D. A.
    Nalam, M. N. L.
    Ozen, A.
    Cai, Y.
    Cao, H.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2014, 19 : A155 - A155
  • [46] Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance
    Weikl, Thomas R.
    Hemmateenejad, Bahram
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2020, 88 (03) : 476 - 484
  • [47] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance
    Das, Debananda
    GLOBAL HEALTH & MEDICINE, 2024, 6 (06): : 357 - 362
  • [48] Implications of substrate shape on inhibitor binding and drug resistance: the crystal structure of RO1 in complex with HIV-1 protease
    Prabu-Jeyabalan, M
    King, N
    Nalivaika, E
    Heilek-Snyder, G
    Cammack, N
    Schiffer, C
    ANTIVIRAL THERAPY, 2005, 10 : S85 - S85
  • [49] Implications of substrate shape on inhibitor binding and drug resistance: the crystal structure of RO1 in complex with HIV-1 protease
    Prabu-Jeyabalan, M
    King, N
    Nalivaika, E
    Heilek-Snyder, G
    Cammack, N
    Schiffer, C
    ANTIVIRAL THERAPY, 2005, 10 (04) : S85 - S85
  • [50] Optimization of a macromolecular inhibitor of HIV-1 protease
    Dauber, DS
    McPhee, F
    Ünal, A
    Craik, CS
    ASPARTIC PROTEINASES: RETROVIRAL AND CELLULAR ENZYMES, 1998, 436 : 65 - 70
12345